Standard Glass Lining Shares made a strong debut on January 13, 2025, with shares listing at ₹172 on the NSE, a 22.8% premium from the issue price of ₹140. On the BSE, the stock opened at ₹176, up 25.71% from the issue price.
Overview of Contents
Standard Glass Lining Subscription Status
The IPO saw robust participation across categories, with 2,08,29,567 shares offered and bids totaling 3,81,56,56,808 shares, achieving an overall subscription of 183.18 times. Qualified Institutional Buyers (QIBs) led with 331.60 times subscription, driven by Foreign Institutional Investors (FIIs) and Domestic Financial Institutions. Non-Institutional Investors (NIIs) subscribed 268.50 times, with bids of more than ₹10 lakh reaching 294.28 times. Retail Individual Investors (RIIs) subscribed 64.99 times, with significant interest in cutoff bids. This overwhelming demand underscores strong investor confidence.
Standard Glass Lining IPO GMP
The Standard Glass Lining IPO is trading at a grey market premium (GMP) of ₹50 per share, indicating a potential listing gain of 34-35% over the issue price. Notably, the GMP peaked at ₹90-95 on the final bidding day, reflecting strong investor interest in the unofficial market.
Details About Standard Glass Lining IPO
The Standard Glass Lining IPO, a ₹410.05 crore Book Built Issue, was open for subscription from January 6 to January 8, 2025, with a price band of ₹133-₹140 per share and a lot size of 107 shares. The IPO included a fresh issue of ₹210 crores and an offer for sale of 1.43 crore shares. With a strong response, the company is set to list on the BSE and NSE on January 13, 2025. Its solid financial growth in 2024, with revenue and profit increases compared to 2023, reflects its promising potential.
- QIB (Qualified Institutional Buyers): 50% of the IPO is reserved for QIBs.
- HNI (High Net-Worth Individuals): 15% of the IPO is allocated for HNIs.
- Retail Investors: 35% of the IPO is reserved for retail investors.
Standard Glass Lining Financial Background
As of September 30, 2024, Standard Glass Lining reported assets of ₹756.52 Cr, revenue of ₹312.10 Cr, and a profit after tax of ₹36.27 Cr. This reflects consistent growth compared to March 2024, where assets stood at ₹665.38 Cr, revenue at ₹549.68 Cr, and profit at ₹60.01 Cr. The company’s net worth increased to ₹447.80 Cr from ₹409.92 Cr, supported by reserves of ₹261.58 Cr and manageable borrowings of ₹173.80 Cr, highlighting its strong financial trajectory over recent years.
Standard Glass Lining IPO Dates
| IPO Open Date: | January 6, 2025 |
| IPO Close Date: | January 8, 2025 |
| Basis of Allotment: | January 9, 2025 |
| Refunds: | January 10, 2025 |
| Credit to Demat Account: | January 10, 2025 |
| IPO Listing Date: | January 13, 2025 |
About Standard Glass Lining Company
Founded in September 2012, Standard Glass Lining Technology Limited is a leading manufacturer of engineering equipment for the pharmaceutical and chemical sectors in India. The company offers turnkey solutions, including design, manufacturing, installation, and operational support, with a diverse product range like reaction systems and plant engineering services.
It serves top clients like Aurobindo Pharma and Laurus Labs, supported by eight manufacturing units in Hyderabad and a nationwide sales network. Employing over 1,190 workers, the company’s strengths include advanced facilities, innovative solutions, and strong client relationships, making it a trusted industry partner.